{"basic_info": {"ticker": "603707", "exchange": "XSHG", "bloomberg_ticker": "603707 CH Equity", "name": "NANJING KING-FRIEND BIOCHE-A", "industry": "Pharmaceuticals", "name_chinese_simplified": "健友股份", "period": "2020", "market_value": 33517522944, "total_income": 2469669305, "ccy": "人民币元", "shariah_compliance_summary": "compliant"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 2467303514, "business_income_over_total_income": 0.9990420616253316}, {"shariah_compliance": "unknown", "income": 2365790, "business_income_over_total_income": 0.0009579379697558333}], "details": [{"business_activity_cn": "标准肝素原料药", "business_activity_en": "Standard heparin API", "income": 1523867346, "business_income_over_total_income": 0.6170329537298112, "shariah_compliance": "compliant"}, {"business_activity_cn": "制剂", "business_activity_en": "preparation", "income": 761910684, "business_income_over_total_income": 0.30850716833118674, "shariah_compliance": "compliant"}, {"business_activity_cn": "CDMO及其他产品", "business_activity_en": "CDMO and other products", "income": 181525484, "business_income_over_total_income": 0.0735019395643337, "shariah_compliance": "compliant"}, {"business_activity_cn": "其他业务", "business_activity_en": "Other business", "income": 2365790, "business_income_over_total_income": 0.0009579379697558333, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": 0.0995923515833862, "shariah_compliance": "compliant", "amount_over_market_value": 0.0995923515833862}]}